

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.15110863 |
| 2 | glutamate secretion (GO:0014047) | 6.93573352 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.65835926 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 6.40046241 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 6.22782589 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.97183261 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.95985922 |
| 8 | vocalization behavior (GO:0071625) | 5.94122310 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.91117751 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.50255741 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.49966758 |
| 12 | protein localization to synapse (GO:0035418) | 5.33104509 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.29124923 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.17611358 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 5.15323583 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 5.07933830 |
| 17 | locomotory exploration behavior (GO:0035641) | 5.03711326 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94494449 |
| 19 | L-amino acid import (GO:0043092) | 4.87236467 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.73809705 |
| 21 | sodium ion export (GO:0071436) | 4.73184872 |
| 22 | positive regulation of synapse maturation (GO:0090129) | 4.72111623 |
| 23 | presynaptic membrane assembly (GO:0097105) | 4.59329003 |
| 24 | proline transport (GO:0015824) | 4.43252894 |
| 25 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.41016491 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.34264026 |
| 27 | amino acid import (GO:0043090) | 4.32065067 |
| 28 | presynaptic membrane organization (GO:0097090) | 4.30394233 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.28645868 |
| 30 | postsynaptic membrane organization (GO:0001941) | 4.27790481 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.27187034 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.26417013 |
| 33 | positive regulation of dendritic spine development (GO:0060999) | 4.21821816 |
| 34 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.16769126 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 4.15440753 |
| 36 | exploration behavior (GO:0035640) | 4.06970462 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.04458273 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03942492 |
| 39 | positive regulation of membrane potential (GO:0045838) | 4.00678158 |
| 40 | regulation of neurotransmitter secretion (GO:0046928) | 3.96918083 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93722727 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.92674903 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.85863354 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.83294653 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.82549557 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 3.82002965 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81447242 |
| 48 | neurotransmitter transport (GO:0006836) | 3.75519215 |
| 49 | axon ensheathment in central nervous system (GO:0032291) | 3.75150650 |
| 50 | central nervous system myelination (GO:0022010) | 3.75150650 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73260885 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.71114927 |
| 53 | long-term synaptic potentiation (GO:0060291) | 3.69282630 |
| 54 | positive regulation of neurotransmitter transport (GO:0051590) | 3.65913066 |
| 55 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.65827393 |
| 56 | potassium ion homeostasis (GO:0055075) | 3.65257444 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.59085245 |
| 58 | neuromuscular synaptic transmission (GO:0007274) | 3.59069990 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.58466275 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.58012468 |
| 61 | dendritic spine organization (GO:0097061) | 3.57559449 |
| 62 | neuronal ion channel clustering (GO:0045161) | 3.56726776 |
| 63 | regulation of ARF protein signal transduction (GO:0032012) | 3.56703876 |
| 64 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.54859483 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.52044158 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.51996715 |
| 67 | regulation of neurotransmitter transport (GO:0051588) | 3.51908001 |
| 68 | long-term memory (GO:0007616) | 3.49180466 |
| 69 | transferrin transport (GO:0033572) | 3.48826028 |
| 70 | negative regulation of dendrite development (GO:2000171) | 3.48823327 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 3.48414762 |
| 72 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.47452352 |
| 73 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.47452352 |
| 74 | potassium ion import (GO:0010107) | 3.46159269 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45029425 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43194264 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.41859630 |
| 78 | activation of protein kinase A activity (GO:0034199) | 3.41378491 |
| 79 | regulation of synapse structural plasticity (GO:0051823) | 3.35907399 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 3.31493292 |
| 81 | cell communication by electrical coupling (GO:0010644) | 3.28581541 |
| 82 | membrane depolarization (GO:0051899) | 3.27403076 |
| 83 | response to histamine (GO:0034776) | 3.26574843 |
| 84 | neuromuscular process controlling posture (GO:0050884) | 3.25781069 |
| 85 | auditory behavior (GO:0031223) | 3.25230783 |
| 86 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.24821976 |
| 87 | mechanosensory behavior (GO:0007638) | 3.23737826 |
| 88 | transmission of nerve impulse (GO:0019226) | 3.22506154 |
| 89 | calcium ion-dependent exocytosis (GO:0017156) | 3.22167050 |
| 90 | acidic amino acid transport (GO:0015800) | 3.21463554 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21407541 |
| 92 | trivalent inorganic cation transport (GO:0072512) | 3.21387992 |
| 93 | ferric iron transport (GO:0015682) | 3.21387992 |
| 94 | neuron recognition (GO:0008038) | 3.21228878 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 3.19838844 |
| 96 | cell migration in hindbrain (GO:0021535) | 3.18382275 |
| 97 | membrane depolarization during action potential (GO:0086010) | 3.18080083 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.17204252 |
| 99 | regulation of dendritic spine development (GO:0060998) | 3.16355276 |
| 100 | phosphorelay signal transduction system (GO:0000160) | 3.15887909 |
| 101 | sleep (GO:0030431) | 3.14098723 |
| 102 | regulation of synaptic transmission (GO:0050804) | 3.13481631 |
| 103 | chemosensory behavior (GO:0007635) | 3.12320890 |
| 104 | regulation of glutamate secretion (GO:0014048) | 3.11492650 |
| 105 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.10923404 |
| 106 | gamma-aminobutyric acid transport (GO:0015812) | 3.10468277 |
| 107 | response to auditory stimulus (GO:0010996) | 3.09178516 |
| 108 | * synaptic transmission (GO:0007268) | 3.08556968 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 3.07952183 |
| 110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.05807757 |
| 111 | cellular sodium ion homeostasis (GO:0006883) | 3.05476661 |
| 112 | dicarboxylic acid transport (GO:0006835) | 3.03471785 |
| 113 | innervation (GO:0060384) | 3.03097842 |
| 114 | long term synaptic depression (GO:0060292) | 3.02598906 |
| 115 | regulation of exocytosis (GO:0017157) | 3.01555428 |
| 116 | neuromuscular process (GO:0050905) | 3.00153616 |
| 117 | vesicle docking involved in exocytosis (GO:0006904) | 2.99719367 |
| 118 | acid secretion (GO:0046717) | 2.99210165 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 2.98453538 |
| 120 | synaptic vesicle transport (GO:0048489) | 2.98453538 |
| 121 | response to gravity (GO:0009629) | 2.98383627 |
| 122 | neurotransmitter uptake (GO:0001504) | 2.96539483 |
| 123 | behavioral response to cocaine (GO:0048148) | 2.95950677 |
| 124 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.95157185 |
| 125 | synapse assembly (GO:0007416) | 2.90090565 |
| 126 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.87907871 |
| 127 | learning (GO:0007612) | 2.85763327 |
| 128 | axonal fasciculation (GO:0007413) | 2.85545170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.25504654 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.16953591 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.42643654 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17787456 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.16212091 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.13203142 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79571893 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78054479 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78054479 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71127091 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68808875 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61478414 |
| 13 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.61122436 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60904647 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.59487685 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.59435948 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59050632 |
| 18 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44287367 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33101935 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31644948 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28893101 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26461705 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19756768 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18618928 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.17464022 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11049891 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99595520 |
| 28 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99520018 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.99259564 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.95476410 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79985299 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77315558 |
| 33 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73281212 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72519453 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71363607 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70045986 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.69987683 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67537841 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62234948 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57702903 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55770736 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50793973 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49044938 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44735285 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43990378 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40933496 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40511759 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38016021 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36706756 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35864931 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35208246 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31189721 |
| 53 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.30359376 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29858816 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27666319 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24908038 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.23349803 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23272396 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22647774 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22208315 |
| 61 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.22097941 |
| 62 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21524012 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20811835 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19751134 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19302902 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17495070 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15436935 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14067193 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13553784 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13159953 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12859944 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.12519138 |
| 73 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11544313 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11329328 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08531653 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08427454 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07944962 |
| 78 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07515158 |
| 79 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06824264 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06225929 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06025226 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04810794 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04668141 |
| 84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04041328 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03918401 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03162468 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02715355 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02433657 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02343742 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01423964 |
| 91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00944263 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 1.00603452 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00388809 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98680639 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98097131 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97541555 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97473823 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97249679 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95751756 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95483133 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95193833 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94712697 |
| 103 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94465870 |
| 104 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.94349151 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93670895 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93168680 |
| 107 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93149237 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92627286 |
| 109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90991396 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89316588 |
| 111 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89248738 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88876339 |
| 113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88482717 |
| 114 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87254323 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87078643 |
| 116 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87028090 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86255489 |
| 118 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86029600 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85478851 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85282358 |
| 121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85159053 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84428056 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84197019 |
| 124 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83847558 |
| 125 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83331686 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83225494 |
| 127 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81713081 |
| 128 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81699458 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81021654 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80478684 |
| 131 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79729027 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79613711 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78736896 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78582174 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.78179896 |
| 136 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76717710 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76481815 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75547858 |
| 139 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.74917666 |
| 140 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.74022659 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72841777 |
| 142 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.72561895 |
| 143 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71073578 |
| 144 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.71069359 |
| 145 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70998163 |
| 146 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69943064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.55569916 |
| 2 | MP0003880_abnormal_central_pattern | 5.39179099 |
| 3 | MP0004270_analgesia | 4.28034689 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.17608921 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.56611439 |
| 6 | MP0009745_abnormal_behavioral_response | 3.52588556 |
| 7 | MP0009046_muscle_twitch | 3.45723128 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.37458332 |
| 9 | MP0002064_seizures | 3.35563792 |
| 10 | MP0002736_abnormal_nociception_after | 3.03470280 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.93936877 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.86783201 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.84666985 |
| 14 | MP0002272_abnormal_nervous_system | 2.59657834 |
| 15 | MP0001486_abnormal_startle_reflex | 2.44605399 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.36650718 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.32534641 |
| 18 | MP0004858_abnormal_nervous_system | 2.32043251 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.31430242 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.18060340 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.13752188 |
| 22 | MP0002822_catalepsy | 2.12804466 |
| 23 | MP0001970_abnormal_pain_threshold | 2.12453391 |
| 24 | MP0003879_abnormal_hair_cell | 2.10638648 |
| 25 | MP0003329_amyloid_beta_deposits | 2.01405774 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.98518345 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.86736760 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.83115308 |
| 29 | MP0008569_lethality_at_weaning | 1.82464963 |
| 30 | MP0002184_abnormal_innervation | 1.80251797 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.61759504 |
| 32 | MP0004924_abnormal_behavior | 1.61759504 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.57003181 |
| 34 | MP0003787_abnormal_imprinting | 1.55946670 |
| 35 | MP0000778_abnormal_nervous_system | 1.53655744 |
| 36 | MP0000920_abnormal_myelination | 1.45639202 |
| 37 | MP0003633_abnormal_nervous_system | 1.42806901 |
| 38 | MP0000955_abnormal_spinal_cord | 1.42228791 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.41199959 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.40699270 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.35679412 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.29410358 |
| 43 | MP0001984_abnormal_olfaction | 1.29226079 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.23352953 |
| 45 | MP0004142_abnormal_muscle_tone | 1.21499591 |
| 46 | MP0008872_abnormal_physiological_respon | 1.20172407 |
| 47 | MP0000751_myopathy | 1.19786572 |
| 48 | MP0001905_abnormal_dopamine_level | 1.19656666 |
| 49 | MP0003631_nervous_system_phenotype | 1.18080295 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.17303257 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.13428296 |
| 52 | MP0001529_abnormal_vocalization | 1.11040479 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.09498991 |
| 54 | MP0003122_maternal_imprinting | 1.07920203 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.07191344 |
| 56 | MP0004885_abnormal_endolymph | 1.07033397 |
| 57 | MP0008874_decreased_physiological_sensi | 1.05301142 |
| 58 | MP0000604_amyloidosis | 0.96378185 |
| 59 | MP0003283_abnormal_digestive_organ | 0.94633558 |
| 60 | MP0010386_abnormal_urinary_bladder | 0.93862943 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.93656798 |
| 62 | MP0004742_abnormal_vestibular_system | 0.93373355 |
| 63 | MP0002152_abnormal_brain_morphology | 0.92964055 |
| 64 | MP0004233_abnormal_muscle_weight | 0.89511569 |
| 65 | MP0005535_abnormal_body_temperature | 0.89412997 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.87302399 |
| 67 | MP0001963_abnormal_hearing_physiology | 0.86412644 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 0.86169766 |
| 69 | MP0002229_neurodegeneration | 0.85905943 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.85098111 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.85053342 |
| 72 | MP0004510_myositis | 0.84573159 |
| 73 | MP0004484_altered_response_of | 0.84408209 |
| 74 | MP0003075_altered_response_to | 0.81377817 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.80483589 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.78439373 |
| 77 | MP0001188_hyperpigmentation | 0.76708127 |
| 78 | MP0004085_abnormal_heartbeat | 0.76449481 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.73895991 |
| 80 | MP0003646_muscle_fatigue | 0.72144464 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.70759296 |
| 82 | MP0000026_abnormal_inner_ear | 0.69761738 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 0.68981324 |
| 84 | MP0003632_abnormal_nervous_system | 0.68376644 |
| 85 | MP0003634_abnormal_glial_cell | 0.68298007 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.66745676 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.66121804 |
| 88 | MP0005499_abnormal_olfactory_system | 0.66121804 |
| 89 | MP0004043_abnormal_pH_regulation | 0.65259761 |
| 90 | MP0000579_abnormal_nail_morphology | 0.65000069 |
| 91 | MP0003123_paternal_imprinting | 0.64997179 |
| 92 | MP0005171_absent_coat_pigmentation | 0.63693043 |
| 93 | MP0005187_abnormal_penis_morphology | 0.63229871 |
| 94 | MP0008260_abnormal_autophagy | 0.62833107 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.61203431 |
| 96 | MP0003045_fibrosis | 0.61180804 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.60917086 |
| 98 | MP0000569_abnormal_digit_pigmentation | 0.60574413 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.59285898 |
| 100 | MP0001664_abnormal_digestion | 0.59013109 |
| 101 | MP0003690_abnormal_glial_cell | 0.57191094 |
| 102 | MP0002249_abnormal_larynx_morphology | 0.57033038 |
| 103 | MP0000566_synostosis | 0.56421507 |
| 104 | MP0004147_increased_porphyrin_level | 0.56244348 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.55921419 |
| 106 | MP0005166_decreased_susceptibility_to | 0.54763202 |
| 107 | MP0002090_abnormal_vision | 0.53433437 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.53044035 |
| 109 | MP0005377_hearing/vestibular/ear_phenot | 0.52649589 |
| 110 | MP0003878_abnormal_ear_physiology | 0.52649589 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.51748997 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.51634793 |
| 113 | MP0010769_abnormal_survival | 0.51475925 |
| 114 | MP0001177_atelectasis | 0.51021294 |
| 115 | MP0003938_abnormal_ear_development | 0.49835132 |
| 116 | MP0001943_abnormal_respiration | 0.49790611 |
| 117 | MP0004130_abnormal_muscle_cell | 0.49657961 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.49638440 |
| 119 | MP0002082_postnatal_lethality | 0.49363501 |
| 120 | MP0010770_preweaning_lethality | 0.49363501 |
| 121 | MP0010768_mortality/aging | 0.48619403 |
| 122 | MP0003956_abnormal_body_size | 0.47569099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.32971992 |
| 2 | Myokymia (HP:0002411) | 6.97640473 |
| 3 | Epileptic encephalopathy (HP:0200134) | 6.52163692 |
| 4 | Atonic seizures (HP:0010819) | 6.26962115 |
| 5 | Focal seizures (HP:0007359) | 6.15583455 |
| 6 | Febrile seizures (HP:0002373) | 5.21712733 |
| 7 | Visual hallucinations (HP:0002367) | 5.13194897 |
| 8 | Absence seizures (HP:0002121) | 4.92471088 |
| 9 | Dialeptic seizures (HP:0011146) | 4.61557725 |
| 10 | Hyperventilation (HP:0002883) | 4.58953357 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.29774697 |
| 12 | Broad-based gait (HP:0002136) | 3.93295921 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.92644046 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.76857602 |
| 15 | Action tremor (HP:0002345) | 3.72258063 |
| 16 | Poor eye contact (HP:0000817) | 3.59044631 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.57683185 |
| 18 | Amblyopia (HP:0000646) | 3.49752904 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.29139499 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.29059881 |
| 21 | Dysmetric saccades (HP:0000641) | 3.27337991 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23202593 |
| 23 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.20969551 |
| 24 | Tetraplegia (HP:0002445) | 3.20280919 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.19207637 |
| 26 | Impaired social interactions (HP:0000735) | 3.18241925 |
| 27 | Abnormal social behavior (HP:0012433) | 3.18241925 |
| 28 | Ankle clonus (HP:0011448) | 3.16354819 |
| 29 | Limb dystonia (HP:0002451) | 3.11368515 |
| 30 | Truncal ataxia (HP:0002078) | 3.00349722 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 2.92330341 |
| 32 | Neuronal loss in central nervous system (HP:0002529) | 2.90987545 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 2.90439788 |
| 34 | Depression (HP:0000716) | 2.86118290 |
| 35 | Clonus (HP:0002169) | 2.84850077 |
| 36 | Intention tremor (HP:0002080) | 2.84649819 |
| 37 | Urinary urgency (HP:0000012) | 2.84040836 |
| 38 | Delusions (HP:0000746) | 2.82188180 |
| 39 | Termporal pattern (HP:0011008) | 2.79463698 |
| 40 | Insidious onset (HP:0003587) | 2.79463698 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.77803087 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.77744514 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.76511297 |
| 44 | Excessive salivation (HP:0003781) | 2.73965352 |
| 45 | Drooling (HP:0002307) | 2.73965352 |
| 46 | Pheochromocytoma (HP:0002666) | 2.72587441 |
| 47 | Status epilepticus (HP:0002133) | 2.72234437 |
| 48 | Fetal akinesia sequence (HP:0001989) | 2.70675082 |
| 49 | Spastic tetraparesis (HP:0001285) | 2.66195407 |
| 50 | Polyphagia (HP:0002591) | 2.60341214 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.57965515 |
| 52 | Anxiety (HP:0000739) | 2.57867524 |
| 53 | Dysmetria (HP:0001310) | 2.57636204 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.55634476 |
| 55 | Inability to walk (HP:0002540) | 2.53548830 |
| 56 | Apathy (HP:0000741) | 2.51224328 |
| 57 | Stereotypic behavior (HP:0000733) | 2.50527923 |
| 58 | Mutism (HP:0002300) | 2.49937149 |
| 59 | Impaired vibratory sensation (HP:0002495) | 2.49813485 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.49285039 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.48643154 |
| 62 | Torticollis (HP:0000473) | 2.44466003 |
| 63 | Insomnia (HP:0100785) | 2.42793196 |
| 64 | Spastic gait (HP:0002064) | 2.42714185 |
| 65 | Postural instability (HP:0002172) | 2.41286080 |
| 66 | Focal dystonia (HP:0004373) | 2.36997830 |
| 67 | Bradykinesia (HP:0002067) | 2.36169122 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.34585366 |
| 69 | Abnormality of the labia minora (HP:0012880) | 2.34443814 |
| 70 | Bundle branch block (HP:0011710) | 2.27254757 |
| 71 | Genetic anticipation (HP:0003743) | 2.25923316 |
| 72 | Turricephaly (HP:0000262) | 2.25120805 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23990472 |
| 74 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23990472 |
| 75 | Aplasia involving bones of the extremities (HP:0009825) | 2.23990472 |
| 76 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.23155343 |
| 77 | Rigidity (HP:0002063) | 2.23110784 |
| 78 | Diminished motivation (HP:0000745) | 2.22855648 |
| 79 | Abnormal hair whorl (HP:0010721) | 2.21027993 |
| 80 | Protruding tongue (HP:0010808) | 2.16631594 |
| 81 | Progressive inability to walk (HP:0002505) | 2.16163907 |
| 82 | Bronchomalacia (HP:0002780) | 2.15391839 |
| 83 | Hemiparesis (HP:0001269) | 2.14296093 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.12249870 |
| 85 | Poor suck (HP:0002033) | 2.11203879 |
| 86 | Failure to thrive in infancy (HP:0001531) | 2.10798773 |
| 87 | Abnormality of the corticospinal tract (HP:0002492) | 2.09786989 |
| 88 | CNS hypomyelination (HP:0003429) | 2.07792591 |
| 89 | Scanning speech (HP:0002168) | 2.07745347 |
| 90 | Megalencephaly (HP:0001355) | 2.07544575 |
| 91 | Abnormality of pain sensation (HP:0010832) | 2.05338593 |
| 92 | Impaired pain sensation (HP:0007328) | 2.05338593 |
| 93 | Diplopia (HP:0000651) | 2.03511705 |
| 94 | Abnormality of binocular vision (HP:0011514) | 2.03511705 |
| 95 | Incomplete penetrance (HP:0003829) | 2.03412498 |
| 96 | Craniofacial dystonia (HP:0012179) | 2.02973121 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.02644429 |
| 98 | Generalized myoclonic seizures (HP:0002123) | 2.02443356 |
| 99 | Annular pancreas (HP:0001734) | 2.02284116 |
| 100 | Absent speech (HP:0001344) | 2.02089205 |
| 101 | Oligomenorrhea (HP:0000876) | 1.97933036 |
| 102 | Specific learning disability (HP:0001328) | 1.96185598 |
| 103 | Gait imbalance (HP:0002141) | 1.93788452 |
| 104 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91270886 |
| 105 | Heart block (HP:0012722) | 1.90840162 |
| 106 | Large eyes (HP:0001090) | 1.90564903 |
| 107 | Akinesia (HP:0002304) | 1.90511523 |
| 108 | Short chin (HP:0000331) | 1.90052945 |
| 109 | Spinal canal stenosis (HP:0003416) | 1.89609905 |
| 110 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89000281 |
| 111 | Hemiplegia (HP:0002301) | 1.88310427 |
| 112 | Gait ataxia (HP:0002066) | 1.87767489 |
| 113 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86356654 |
| 114 | Hypoventilation (HP:0002791) | 1.85217252 |
| 115 | Choreoathetosis (HP:0001266) | 1.85086567 |
| 116 | Abnormality of salivation (HP:0100755) | 1.84956561 |
| 117 | Generalized hypotonia (HP:0001290) | 1.84426727 |
| 118 | Atrioventricular block (HP:0001678) | 1.83376990 |
| 119 | Lower limb asymmetry (HP:0100559) | 1.82337984 |
| 120 | Resting tremor (HP:0002322) | 1.80729612 |
| 121 | Lower limb amyotrophy (HP:0007210) | 1.80634771 |
| 122 | Sensory axonal neuropathy (HP:0003390) | 1.80042000 |
| 123 | Split foot (HP:0001839) | 1.78601756 |
| 124 | Increased circulating renin level (HP:0000848) | 1.78600622 |
| 125 | Thickened helices (HP:0000391) | 1.78453759 |
| 126 | Abnormality of the periventricular white matter (HP:0002518) | 1.77287810 |
| 127 | Slow saccadic eye movements (HP:0000514) | 1.76183114 |
| 128 | Shoulder girdle muscle weakness (HP:0003547) | 1.75324145 |
| 129 | Prolonged QT interval (HP:0001657) | 1.73138434 |
| 130 | Abnormality of saccadic eye movements (HP:0000570) | 1.72704886 |
| 131 | Papilledema (HP:0001085) | 1.72530929 |
| 132 | Hyperthyroidism (HP:0000836) | 1.72447632 |
| 133 | Abnormal atrioventricular conduction (HP:0005150) | 1.72233324 |
| 134 | Sleep apnea (HP:0010535) | 1.72108022 |
| 135 | Narrow nasal bridge (HP:0000446) | 1.71460145 |
| 136 | Dementia (HP:0000726) | 1.68929362 |
| 137 | Abnormal EKG (HP:0003115) | 1.67208322 |
| 138 | Nonprogressive disorder (HP:0003680) | 1.66601474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.17110606 |
| 2 | NTRK3 | 4.04104167 |
| 3 | EPHA4 | 3.95970817 |
| 4 | DAPK2 | 3.72108105 |
| 5 | MAP3K9 | 3.54281834 |
| 6 | MAP3K4 | 2.99112354 |
| 7 | MAP3K12 | 2.92306536 |
| 8 | MAP2K7 | 2.71133528 |
| 9 | CDK19 | 2.67628684 |
| 10 | DAPK1 | 2.54556260 |
| 11 | MINK1 | 2.52285729 |
| 12 | PLK2 | 2.30539335 |
| 13 | CCNB1 | 2.27124522 |
| 14 | MARK1 | 2.21083073 |
| 15 | MAP2K4 | 2.01716537 |
| 16 | PAK6 | 1.97982993 |
| 17 | RIPK4 | 1.76739958 |
| 18 | AKT3 | 1.70501476 |
| 19 | KSR2 | 1.67888366 |
| 20 | NTRK1 | 1.65200910 |
| 21 | ARAF | 1.58934642 |
| 22 | CAMKK1 | 1.57158437 |
| 23 | GRK5 | 1.52840901 |
| 24 | PRPF4B | 1.51661380 |
| 25 | NTRK2 | 1.36788013 |
| 26 | PNCK | 1.36493061 |
| 27 | CDK5 | 1.31615712 |
| 28 | CAMKK2 | 1.30716668 |
| 29 | KSR1 | 1.30537985 |
| 30 | OXSR1 | 1.30020056 |
| 31 | PRKCG | 1.20969476 |
| 32 | MARK2 | 1.19209763 |
| 33 | NEK1 | 1.14321977 |
| 34 | MAPK13 | 1.11607721 |
| 35 | PTK2B | 1.04268169 |
| 36 | PDK4 | 1.01252532 |
| 37 | PDK3 | 1.01252532 |
| 38 | STK38 | 1.01072401 |
| 39 | PKN1 | 1.00806746 |
| 40 | PRKD3 | 1.00438732 |
| 41 | DAPK3 | 1.00348200 |
| 42 | SIK3 | 0.96900582 |
| 43 | LATS2 | 0.87146029 |
| 44 | CDK18 | 0.87065879 |
| 45 | STK16 | 0.86150410 |
| 46 | CAMK2A | 0.83696378 |
| 47 | SGK494 | 0.82647672 |
| 48 | SGK223 | 0.82647672 |
| 49 | IRAK2 | 0.81703006 |
| 50 | CDK15 | 0.81199656 |
| 51 | CDK14 | 0.80475339 |
| 52 | SIK2 | 0.80162712 |
| 53 | TAOK1 | 0.79995652 |
| 54 | RIPK1 | 0.79376397 |
| 55 | SGK2 | 0.78802716 |
| 56 | MAP3K2 | 0.75894615 |
| 57 | RAF1 | 0.72813316 |
| 58 | NME1 | 0.72666364 |
| 59 | BRAF | 0.72044358 |
| 60 | TSSK6 | 0.71749375 |
| 61 | CAMK1 | 0.71485804 |
| 62 | UHMK1 | 0.70225559 |
| 63 | CDK11A | 0.68889793 |
| 64 | TYRO3 | 0.66456477 |
| 65 | MUSK | 0.66127899 |
| 66 | PDK1 | 0.65418443 |
| 67 | MAP3K13 | 0.64235047 |
| 68 | STK11 | 0.63939441 |
| 69 | MAP3K11 | 0.62662154 |
| 70 | TNK2 | 0.61410773 |
| 71 | PDPK1 | 0.61207228 |
| 72 | LIMK1 | 0.59252426 |
| 73 | MAPK10 | 0.57861728 |
| 74 | CAMK2B | 0.57385166 |
| 75 | SGK3 | 0.57137630 |
| 76 | BMPR2 | 0.56535964 |
| 77 | PHKG2 | 0.55952623 |
| 78 | PHKG1 | 0.55952623 |
| 79 | LMTK2 | 0.55781733 |
| 80 | TNIK | 0.52832994 |
| 81 | FES | 0.51913649 |
| 82 | PRKCH | 0.50931105 |
| 83 | SGK1 | 0.50164819 |
| 84 | ALK | 0.49899983 |
| 85 | RET | 0.49698277 |
| 86 | MAP2K1 | 0.48362094 |
| 87 | PRKG2 | 0.47951264 |
| 88 | PDK2 | 0.47556625 |
| 89 | FER | 0.47453507 |
| 90 | MAPK12 | 0.46497126 |
| 91 | CAMK1D | 0.46074539 |
| 92 | MAP2K6 | 0.45753773 |
| 93 | PRKCE | 0.44272196 |
| 94 | DYRK1A | 0.42077710 |
| 95 | MAPK7 | 0.41465049 |
| 96 | CSNK1G2 | 0.38180438 |
| 97 | NEK6 | 0.36890735 |
| 98 | PAK3 | 0.36545838 |
| 99 | FGR | 0.36320185 |
| 100 | CAMK4 | 0.35841499 |
| 101 | FYN | 0.35168606 |
| 102 | ADRBK1 | 0.34787245 |
| 103 | BRSK1 | 0.34722851 |
| 104 | MAP3K1 | 0.34055143 |
| 105 | ERBB2 | 0.33609078 |
| 106 | PRKCA | 0.33593096 |
| 107 | RPS6KA3 | 0.33583261 |
| 108 | PINK1 | 0.33486417 |
| 109 | CAMK2G | 0.32125926 |
| 110 | MAPK8 | 0.28782427 |
| 111 | ROCK1 | 0.28353597 |
| 112 | BCR | 0.27960654 |
| 113 | CDC42BPA | 0.27454041 |
| 114 | PRKCZ | 0.27323915 |
| 115 | PAK1 | 0.25017354 |
| 116 | PLK3 | 0.24396208 |
| 117 | PRKG1 | 0.23732357 |
| 118 | ROCK2 | 0.23484253 |
| 119 | CAMK2D | 0.23451831 |
| 120 | CAMK1G | 0.21786075 |
| 121 | MOS | 0.20715089 |
| 122 | RPS6KB1 | 0.20466098 |
| 123 | TESK1 | 0.20409011 |
| 124 | PRKACA | 0.20308604 |
| 125 | ABL2 | 0.20160058 |
| 126 | DDR2 | 0.19997844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.43964557 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88996743 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.95118751 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75885990 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71705753 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69887932 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60971418 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53641857 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39990289 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38177700 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.31755281 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.16540296 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.16093372 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.04990138 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00173775 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88180220 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.78921576 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.69784011 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67581252 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66439731 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.64646928 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.64549123 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56754452 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54761511 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49304491 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48329595 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.45702997 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.39744067 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34089436 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33364914 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.22762539 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18302494 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15686041 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12544368 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12216745 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10762154 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10493784 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07641201 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.07550778 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06845731 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05353468 |
| 42 | Alcoholism_Homo sapiens_hsa05034 | 1.05200371 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03503944 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02333763 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01916182 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01077579 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97179820 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93925355 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88605055 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88383995 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.88011211 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.86975278 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81654690 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79313314 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77823837 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72860660 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.72669593 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68709821 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67148394 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66119618 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63886947 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63763723 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61983867 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61099397 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57345144 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56869517 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53997945 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.53678401 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53582250 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53203886 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52444646 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51255159 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50672044 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50327188 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49625018 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48863820 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48035277 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47584917 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47350442 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46001895 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45251299 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45185045 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44046490 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43127244 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43062700 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40894101 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.40016960 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39716728 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39120523 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38378117 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38236248 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.37374126 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36637137 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35921086 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32922314 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32861113 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32664593 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32660089 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.31385299 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31343835 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28874404 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27248978 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27184795 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26114776 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25564733 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24872834 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24780295 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24448268 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24202837 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23723815 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23682521 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.23261865 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22782759 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.20787371 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19428530 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15809937 |

